0,897  0,003  Caspase 9 stimulant
0,887  0,004  Aldehyde oxidase inhibitor
0,866  0,002  Antimutagenic
0,857  0,004  Tubulin antagonist
0,847  0,005  Antineoplastic (breast cancer)
0,833  0,006  Antineoplastic (lung cancer)
0,832  0,005  Antineoplastic (colorectal cancer)
0,838  0,012  Apoptosis agonist
0,829  0,005  Antineoplastic (colon cancer)
0,777  0,004  CYP1A2 inhibitor
0,771  0,005  Antineoplastic (cervical cancer)
0,770  0,004  Caspase 3 stimulant
0,752  0,003  Breast cancer-resistant protein inhibitor
0,750  0,006  Prostate cancer treatment
0,748  0,005  CTGF expression inhibitor
0,741  0,005  NOS2 expression inhibitor
0,745  0,009  Antileukemic
0,729  0,005  UGT1A9 substrate
0,721  0,004  Histamine release inhibitor
0,714  0,005  Amyloid beta aggregation inhibitor
0,712  0,005  UGT1A6 substrate
0,702  0,005  Free radical scavenger
0,697  0,005  AR expression inhibitor
0,691  0,004  P-glycoprotein inhibitor
0,684  0,006  Antineoplastic (non-small cell lung cancer)
0,691  0,014  TNF expression inhibitor
0,680  0,006  Antioxidant
0,673  0,005  5 Hydroxytryptamine release inhibitor
0,671  0,008  Antineoplastic (melanoma)
0,665  0,005  Antimitotic
0,653  0,006  Cardioprotectant
0,651  0,004  Antineoplastic (gastric cancer)
0,644  0,004  GABA C receptor rho-3 antagonist
0,637  0,005  Antineoplastic (carcinoma)
0,630  0,003  Alpha tubulin antagonist
0,629  0,004  Acetylcholinesterase inhibitor
0,627  0,005  Antineoplastic enhancer
0,612  0,007  Antiprotozoal (Leishmania)
0,609  0,014  Aryl hydrocarbon receptor agonist
0,607  0,015  Antineoplastic (ovarian cancer)
0,598  0,016  Chemoprotective
0,577  0,005  Antineoplastic (squamous cell carcinoma)
0,577  0,005  Cholinergic
0,574  0,005  UGT1A3 substrate
0,598  0,031  Transcription factor NF kappa B inhibitor
0,569  0,011  Antineoplastic (glioma)
0,561  0,004  Beta tubulin antagonist
0,567  0,009  Vasodilator, coronary
0,552  0,003  UGT2B15 substrate
0,560  0,015  Cytostatic
0,560  0,015  Chemopreventive
0,553  0,010  Tumour necrosis factor alpha release inhibitor
0,550  0,009  Superoxide dismutase inhibitor
0,551  0,014  Ulceration
0,538  0,008  UGT1A1 substrate
0,548  0,020  Antipruritic, allergic
0,555  0,031  15-Lipoxygenase inhibitor
0,526  0,003  Cystathionine beta-synthase inhibitor
0,520  0,007  Antineoplastic (sarcoma)
0,511  0,004  NADPH oxidase inhibitor
0,517  0,016  Antineoplastic (multiple myeloma)
0,503  0,009  Peroxidase inhibitor
0,507  0,020  12-Lipoxygenase inhibitor
0,497  0,011  UGT2B4 substrate
0,499  0,014  Antineoplastic (glioblastoma multiforme)
0,502  0,024  CYP1A2 substrate
0,503  0,025  Antihypercholesterolemic
0,495  0,020  Antineoplastic (brain cancer)
0,501  0,027  5 Hydroxytryptamine release stimulant
0,491  0,019  Proliferative diseases treatment
0,495  0,025  CYP2C19 inhibitor
0,480  0,013  Antineoplastic (osteosarcoma)
0,472  0,006  Amylase inhibitor
0,478  0,016  DNA damaging
0,486  0,025  Spasmolytic
0,478  0,018  Antiamyloidogenic
0,462  0,003  GABA C receptor rho-2 antagonist
0,464  0,005  Butyrylcholinesterase inhibitor
0,480  0,021  Lipoxygenase inhibitor
0,457  0,005  Tumour necrosis factor antagonist
0,469  0,018  Hypoxia-inducible factor 1 alpha inhibitor
0,456  0,010  Antineoplastic (bladder cancer)
0,470  0,025  Antineoplastic (pancreatic cancer)
0,451  0,007  5 Hydroxytryptamine uptake stimulant
0,467  0,025  NOS3 expression inhibitor
0,455  0,014  Antineoplastic (renal cancer)
0,517  0,076  Alpha-glucosidase inhibitor
0,444  0,005  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,456  0,023  Cardiovascular analeptic
0,451  0,020  Nitric oxide antagonist
0,444  0,014  RNA-directed DNA polymerase inhibitor
0,440  0,010  Hepatoprotectant
0,429  0,012  UGT1A4 substrate
0,479  0,064  Antineoplastic (solid tumors)
0,414  0,005  CYP2B6 inhibitor
0,424  0,019  Antihypertriglyceridemic
0,412  0,009  Topoisomerase II inhibitor
0,422  0,020  Vasodilator
0,412  0,011  Melanin inhibitor
0,436  0,035  FMO1 substrate
0,409  0,008  MAO A inhibitor
0,405  0,011  GST M1-1 substrate
0,396  0,005  Antihemorrhagic
0,412  0,021  Antineoplastic (liver cancer)
0,420  0,033  Apoptosis antagonist
0,392  0,012  MAO inhibitor
0,390  0,010  VCAM1 expression inhibitor
0,383  0,011  Genotoxic
0,397  0,025  Antihypoxic
0,407  0,037  Radioprotector
0,374  0,005  Topoisomerase II alpha inhibitor
0,372  0,004  Antineoplastic (uterine cancer)
0,396  0,029  Radiosensitizer
0,379  0,014  Skin whitener
0,386  0,022  Antineoplastic (small cell lung cancer)
0,382  0,022  Antineoplastic (lymphocytic leukemia)
0,424  0,066  Calcium channel L-type activator
0,380  0,023  UDP-glucuronosyltransferase substrate
0,418  0,062  Antiprotozoal
0,360  0,005  Interleukin 4 antagonist
0,358  0,004  Electron transport complex I inhibitor
0,356  0,003  Multidrug resistance-associated protein 1 inhibitor
0,369  0,018  Dual specificity phosphatase inhibitor
0,456  0,107  Antiinflammatory
0,373  0,031  Cardiodepressant
0,388  0,047  Hepatic disorders treatment
0,368  0,028  Pyruvate kinase inhibitor
0,359  0,019  Dual specificity phosphatase 3 inhibitor
0,362  0,023  Cyclic AMP phosphodiesterase inhibitor
0,350  0,012  Protein kinase stimulant
0,342  0,004  VEGF expression inhibitor
0,395  0,060  CYP2C9 inhibitor
0,369  0,034  Hypoglycemic
0,348  0,014  Monophenol monooxygenase inhibitor
0,337  0,005  Nitric-oxide synthase stimulant
0,369  0,038  Calcium channel activator
0,343  0,014  Lipid peroxidase inhibitor
0,393  0,065  CYP2C9 substrate
0,334  0,007  SULT1A3 substrate
0,338  0,016  Pneumotoxic
0,327  0,005  LDLR expression enhancer
0,342  0,021  Non-steroidal antiinflammatory agent
0,350  0,033  Vascular (periferal) disease treatment
0,360  0,048  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,312  0,005  Carbonic anhydrase XIII inhibitor
0,376  0,069  CYP3A4 substrate
0,379  0,073  Prostaglandin dehydrogenase inhibitor
0,341  0,043  Antipyretic
0,338  0,039  Antidiabetic symptomatic
0,340  0,043  Antiprotozoal (Trypanosoma)
0,301  0,004  Creatine kinase inhibitor
0,302  0,009  Gout treatment
0,347  0,063  ICAM1 expression inhibitor
0,287  0,004  Antihelmintic (Trematoda)
0,287  0,005  Aldose reductase inhibitor
0,352  0,071  Antiprotozoal (Plasmodium)
0,285  0,005  Gastritis treatment
0,307  0,028  Antihypotensive
0,287  0,008  Xanthine oxidase inhibitor
0,382  0,106  Alzheimer's disease treatment
0,344  0,073  Angiogenesis inhibitor
0,292  0,024  Antiseptic
0,273  0,006  Phosphodiesterase 4D inhibitor
0,273  0,007  SULT1A1 substrate
0,342  0,077  Vasodilator, peripheral
0,269  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,271  0,008  Histidine decarboxylase inhibitor
0,322  0,060  Sodium/bile acid cotransporter inhibitor
0,277  0,015  Antineoplastic (bone cancer)
0,275  0,015  MAO B inhibitor
0,305  0,051  Cytotoxic
0,290  0,037  Platelet adhesion inhibitor
0,282  0,031  UGT2B7 substrate
0,261  0,010  UGT2B10 substrate
0,254  0,004  GABA C receptor rho-1 antagonist
0,264  0,015  Antiprotozoal (Coccidial)
0,294  0,045  Mutagenic
0,259  0,011  Phobic disorders treatment
0,263  0,015  Carcinogenic, group 1
0,308  0,064  CYP2C19 substrate
0,257  0,015  5-Lipoxygenase inhibitor
0,257  0,020  Succinate dehydrogenase inhibitor
0,243  0,009  Carbonic anhydrase VI inhibitor
0,304  0,074  Respiratory analeptic
0,233  0,009  Phosphodiesterase IV inhibitor
0,239  0,019  Topoisomerase I inhibitor
0,272  0,052  5 Hydroxytryptamine 1E antagonist
0,227  0,010  Calcium antagonist
0,246  0,029  3C-like protease (Human coronavirus) inhibitor
0,228  0,014  Carbonic anhydrase XV inhibitor
0,295  0,082  CYP3A4 inhibitor
0,235  0,023  Alkaline phosphatase inhibitor
0,295  0,084  CYP2D6 substrate
0,313  0,103  GST A substrate
0,272  0,062  Sensitization
0,219  0,013  Carbonic anhydrase III inhibitor
0,234  0,030  NOS3 expression enhancer
0,233  0,030  Cyclooxygenase inhibitor
0,249  0,048  DNA methyltransferase I inhibitor
0,209  0,008  Aromatase inhibitor
0,272  0,072  Transcription factor STAT inhibitor
0,221  0,023  Aldehyde dehydrogenase inhibitor
0,252  0,054  Carcinogenic
0,215  0,018  Toll-Like receptor 2 antagonist
0,223  0,029  UGT2B9 substrate
0,215  0,021  Antitussive
0,205  0,012  Beta glucuronidase inhibitor
0,338  0,145  DNA polymerase beta inhibitor
0,286  0,093  Bone diseases treatment
0,237  0,045  I kappa B kinase epsilon inhibitor
0,205  0,014  Mediator release inhibitor
0,254  0,065  Antineoplastic (lymphoma)
0,206  0,016  Sulfotransferase substrate
0,202  0,012  GABA C receptor antagonist
0,267  0,081  Antiosteoporotic
0,224  0,038  Protein-tyrosine phosphatase inhibitor
0,209  0,025  Arachidonic acid antagonist
0,200  0,017  Choleretic
0,213  0,029  Cyclooxygenase 1 inhibitor
0,210  0,028  Cyclooxygenase 2 inhibitor
0,202  0,020  CF transmembrane conductance regulator agonist
0,188  0,007  Cyclin B3 inhibitor
0,198  0,019  Cyclooxygenase 3 inhibitor
0,204  0,025  Alkylator
0,188  0,011  DNA repair enzyme inhibitor
0,278  0,104  Antithrombotic
0,206  0,032  M18 aspartyl aminopeptidase inhibitor
0,187  0,014  Papain-like protease (SARS coronavirus) inhibitor
0,187  0,015  Telomerase inhibitor
0,201  0,030  Mannose-6-phosphate isomerase inhibitor
0,266  0,096  Analeptic
0,181  0,011  Heat shock protein 70 antagonist
0,258  0,089  Insulysin inhibitor
0,243  0,075  Tyrosine 3 hydroxylase inhibitor
0,221  0,058  Neurotrophic factor enhancer
0,179  0,016  Uric acid excretion stimulant
0,297  0,138  Antibacterial
0,318  0,161  MAP kinase 1 inhibitor
0,237  0,080  Teratogen
0,217  0,061  Abortion inducer
0,166  0,011  Antifungal (Pneumocystis)
0,173  0,018  Dementia treatment
0,176  0,024  Coagulant
0,218  0,068  DNA methylase inhibitor
0,204  0,055  Amyloid beta precursor protein antagonist
0,204  0,054  Antiviral (Ebola)
0,167  0,018  Vascular dementia treatment
0,167  0,018  Sphingomyelinase inhibitor
0,163  0,015  DOPA decarboxylase inhibitor
0,152  0,005  Topoisomerase II beta inhibitor
0,152  0,005  DNA-dependent protein kinase inhibitor
0,225  0,079  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,180  0,035  Protein-tyrosine phosphatase 1B inhibitor
0,166  0,023  Photosensitizer
0,156  0,013  Acetylcholine release stimulant
0,159  0,018  Protein kinase C zeta inhibitor
0,219  0,079  Antiviral (West Nile virus)
0,249  0,110  Antifungal
0,173  0,035  Cholesterol synthesis inhibitor
0,185  0,047  Interferon gamma antagonist
0,255  0,118  Antiallergic
0,179  0,043  Hemostatic
0,168  0,034  Antibacterial (Helicobacter pylori)
0,164  0,031  Microtubule formation inhibitor
0,188  0,055  Antirickettsial
0,199  0,068  Antihelmintic
0,152  0,022  Urease inhibitor
0,147  0,017  UGT2B11 substrate
0,182  0,053  Antiviral (Influenza A)
0,161  0,032  Chelator
0,293  0,165  DNA directed DNA polymerase inhibitor
0,178  0,052  Antidote
0,135  0,009  Xanthine dehydrogenase inhibitor
0,135  0,009  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,171  0,045  Bone formation stimulant
0,213  0,088  Angiogenesis stimulant
0,161  0,037  Glutathione S-transferase substrate
0,207  0,082  Antiparasitic
0,139  0,014  Interleukin 5 antagonist
0,128  0,004  Transcription factor RelA inhibitor
0,153  0,030  Antiviral (Papilloma)
0,153  0,031  Mucolytic
0,137  0,015  Ornithine decarboxylase inhibitor
0,134  0,013  Thioredoxin reductase inhibitor
0,157  0,036  Beta amyloid protein antagonist
0,130  0,010  D-Ala-D-Ala ligase inhibitor
0,227  0,106  Antituberculosic
0,133  0,013  Histone deacetylase SIRT1 stimulant
0,133  0,013  Histone deacetylase stimulant
0,237  0,118  Antimycobacterial
0,138  0,020  SULT1E1 substrate
0,138  0,021  Thioredoxin inhibitor
0,152  0,035  Expectorant
0,165  0,048  Antifungal enhancer
0,139  0,022  Antiviral (SARS coronavirus)
0,139  0,022  Antiviral (Coronavirus)
0,171  0,055  Insulin secretagoues
0,135  0,020  Estrogen receptor beta antagonist
0,164  0,049  Carcinogenic, group 3
0,141  0,028  Estrogen antagonist
0,172  0,059  Neurotensin receptor agonist
0,193  0,080  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,238  0,126  Thyroid hormone beta antagonist
0,126  0,015  mTOR complex 2 inhibitor
0,124  0,013  Granulocyte macrophage colony stimulating factor agonist
0,115  0,005  Glutamate (mGluR7) antagonist
0,201  0,091  Embryotoxic
0,205  0,096  Dyrk kinase inhibitor
0,126  0,017  Myeloperoxidase inhibitor
0,131  0,021  Macrophage migration inhibitory factor inhibitor
0,190  0,081  Antiviral (Influenza)
0,188  0,079  Sedative
0,162  0,054  Cytokine production inhibitor
0,158  0,051  Adenylate cyclase stimulant
0,193  0,086  MAP kinase kinase 2 inhibitor
0,149  0,042  Protein kinase (CK2) alpha inhibitor
0,238  0,132  Thyroid hormone antagonist
0,134  0,028  Carcinogenic, group 2A
0,153  0,047  Antiprotozoal (Trichomonas)
0,141  0,036  Alpha 2c adrenoreceptor antagonist
0,114  0,009  Aryl hydrocarbon receptor antagonist
0,148  0,043  DNA intercalator
0,171  0,067  Muscular dystrophy treatment
0,191  0,088  Platelet aggregation inhibitor
0,122  0,019  HIV-1 integrase (3'-Processing) inhibitor
0,188  0,086  Insulin sensitizer
0,150  0,049  Antihyperlipoproteinemic
0,128  0,030  Androgen antagonist
0,192  0,095  Antiulcerative
0,136  0,039  GST P1-1 substrate
0,114  0,018  HIV-1 integrase (Strand Transfer) inhibitor
0,175  0,079  Antipruritic, non-allergic
0,111  0,015  Postmenopausal disorders treatment
0,157  0,061  Lck kinase inhibitor
0,218  0,122  Gastrin inhibitor
0,155  0,060  Toll-Like receptor 9 antagonist
0,170  0,075  Muscle relaxant
0,151  0,057  Interleukin 1 antagonist
0,114  0,021  CDC25A inhibitor
0,111  0,020  Antiviral (Hepatitis A)
0,158  0,067  Heat shock protein 90 antagonist
0,095  0,005  Ryanodine receptor antagonist
0,103  0,013  Protease activated receptor antagonist
0,111  0,022  Estrogen receptor alpha antagonist
0,165  0,076  Aldehyde oxidase substrate
0,135  0,046  Carcinogenic, group 2B
0,097  0,010  Carbonic anhydrase VII inhibitor
0,209  0,122  Transcription factor STAT3 inhibitor
0,177  0,090  Antiarrhythmic
0,128  0,042  AMP-activated protein kinase stimulant
0,155  0,069  Acaricide
0,125  0,040  Antiprotozoal (Toxoplasma)
0,134  0,049  Contraceptive female
0,110  0,025  Keratolytic
0,131  0,047  Antiviral (Influenza B)
0,127  0,042  UGT2B1 substrate
0,117  0,035  Antifungal (Aspergillus)
0,187  0,105  ErbB-1 antagonist
0,092  0,011  Estradiol 17 beta-dehydrogenase inhibitor
0,085  0,005  GABA B receptor antagonist
0,110  0,031  CYP2A6 inhibitor
0,089  0,010  Potassium channel Kv1.3 blocker
0,144  0,070  Skeletal muscle relaxant
0,076  0,004  Nucleoside transporters inhibitor
0,220  0,148  Cholesterol antagonist
0,158  0,088  ATPase inhibitor
0,108  0,037  Antidote, mercury
0,124  0,054  Transcription factor STAT6 inhibitor
0,082  0,012  Postcoital contraceptive
0,096  0,027  Carbonic anhydrase VA inhibitor
0,084  0,017  Fatty acid synthase inhibitor
0,174  0,108  Histone acetyltransferase inhibitor
0,178  0,112  5 Hydroxytryptamine 3E antagonist
0,114  0,049  Bronchodilator
0,081  0,017  Cyclin D1 inhibitor
0,107  0,043  Antineoplastic antibiotic
0,139  0,076  Ca2+-transporting ATPase inhibitor
0,092  0,030  Carbonic anhydrase V inhibitor
0,135  0,073  Psychosexual dysfunction treatment
0,138  0,077  Activin receptor-like kinase 2 inhibitor
0,119  0,059  Alpha 2b adrenoreceptor antagonist
0,094  0,037  Phosphodiesterase 3A inhibitor
0,148  0,091  Mcl-1 antagonist
0,104  0,049  Alcohol dehydrogenase inhibitor
0,208  0,153  FMO3 substrate
0,110  0,055  GST T1-1 substrate
0,110  0,056  Protein kinase (CK2) inhibitor
0,120  0,067  Retinopathy treatment
0,060  0,008  Melatonin 2 agonist
0,076  0,024  Estrogen agonist
0,131  0,079  Antieczematic
0,062  0,011  Neuraminidase (Influenza A) inhibitor
0,067  0,017  CD45 antagonist
0,089  0,039  Ca(v)3.1 blocker
0,072  0,024  Calcium channel P-type blocker
0,069  0,020  Carbonic anhydrase XIV inhibitor
0,085  0,038  Lipase inhibitor
0,076  0,030  Exportin-1 inhibitor
0,158  0,112  Interleukin antagonist
0,143  0,100  Interleukin 6 antagonist
0,114  0,071  Antiprotozoal (Babesia)
0,081  0,039  Phosphodiesterase VI inhibitor
0,094  0,052  Phosphodiesterase I inhibitor
0,102  0,061  Chronic obstructive bronchitis treatment
0,071  0,033  Neuraminidase (influenza) inhibitor
0,138  0,100  Heat shock protein 90 alpha antagonist
0,070  0,033  Antidote, heavy metal
0,069  0,031  Phosphodiesterase 1C inhibitor
0,044  0,008  Estrogen-related receptor beta antagonist
0,052  0,016  Dopamine D5 agonist
0,064  0,029  GABA receptor antagonist
0,098  0,063  Glutamate (mGluR7) agonist
0,074  0,040  Phosphodiesterase III inhibitor
0,072  0,038  Dopamine D1 antagonist
0,077  0,044  Phosphodiesterase V inhibitor
0,090  0,057  NADH dehydrogenase inhibitor
0,093  0,061  Antiviral (Rhinovirus)
0,068  0,036  Beta 3 adrenoreceptor antagonist
0,084  0,052  T cell inhibitor
0,067  0,035  Cyclin B1 inhibitor
0,062  0,030  Cyclin B2 inhibitor
0,064  0,032  Carbonic anhydrase VB inhibitor
0,055  0,024  Factor III inhibitor
0,077  0,047  Glutamate decarboxylase inhibitor
0,148  0,118  Psychostimulant
0,044  0,015  Vanilloid 3 antagonist
0,131  0,102  Hexokinase inhibitor
0,056  0,027  Anesthetic inhalation
0,084  0,055  Inducible nitric-oxide synthase inhibitor
0,116  0,087  Contraceptive
0,116  0,087  Phosphodiesterase inhibitor
0,052  0,023  Benzodiazepine antagonist
0,112  0,084  Antiprotozoal (Amoeba)
0,135  0,107  Uterine stimulant
0,079  0,053  Antidote, organophosphates
0,089  0,064  Alpha adrenoreceptor antagonist
0,055  0,030  Glucose-6-phosphate translocase inhibitor
0,041  0,017  ATM kinase inhibitor
0,109  0,085  Epidermal growth factor receptor kinase inhibitor
0,063  0,040  Neuraminidase inhibitor
0,089  0,065  Glutamate release inhibitor
0,104  0,081  Proteasome inhibitor
0,227  0,204  Transcription factor inhibitor
0,084  0,061  Alpha 2 adrenoreceptor antagonist
0,071  0,049  Phosphodiesterase 5A inhibitor
0,143  0,122  Anesthetic general
0,103  0,082  TRPA1 agonist
0,173  0,152  Streptokinase A inhibitor
0,075  0,055  Na+ K+ transporting ATPase inhibitor
0,182  0,162  Flavin-containing monooxygenase substrate
0,144  0,125  Antiviral (Hepatitis)
0,120  0,101  Cytidine deaminase inhibitor
0,068  0,050  SULT2A1 substrate
0,062  0,044  Nitric oxide donor
0,036  0,018  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,037  0,019  Estrogen-related receptor alpha antagonist
0,049  0,032  Cholesterol esterase inhibitor
0,081  0,064  Estrogen-related receptor beta agonist
0,073  0,056  Arylamine N-Acetyltransferase substrate
0,108  0,093  Proto-oncogene tyrosine-protein kinase Yes inhibitor
0,027  0,013  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,089  0,076  Cyclin-dependent kinase 9 inhibitor
0,147  0,135  Focal adhesion kinase 2 inhibitor
0,090  0,078  Anabolic
0,078  0,066  Caspase 7 inhibitor
0,033  0,022  Melatonin agonist
0,113  0,102  Antiparkinsonian, tremor relieving
0,088  0,077  Interleukin 12 antagonist
0,033  0,023  Melatonin receptor 1A agonist
0,060  0,050  Leukotriene antagonist
0,023  0,014  Estrone sulfatase inhibitor
0,069  0,060  Alpha 1 adrenoreceptor antagonist
0,024  0,014  Monocarboxylic acid transporter 1 inhibitor
0,024  0,014  Monocarboxylic acid transporter inhibitor
0,035  0,026  Inosine monophosphate dehydrogenase inhibitor
0,033  0,024  Melatonin 1 agonist
0,052  0,043  Cyclin B inhibitor
0,104  0,096  Alpha-N-acetylglucosaminidase inhibitor
0,050  0,042  GABA A receptor antagonist
0,065  0,057  Anticholelithogenic
0,082  0,075  Actinic keratosis treatment
0,030  0,024  ATP citrate lysase inhibitor
0,119  0,113  Antiviral (Herpes)
0,013  0,007  Melatonin 2 antagonist
0,014  0,010  Melatonin receptor 1A antagonist
0,066  0,062  Alpha 2a adrenoreceptor antagonist
0,031  0,028  Progesterone antagonist
0,075  0,072  Phosphodiesterase 11A inhibitor
0,075  0,072  Phosphodiesterase XI inhibitor
0,029  0,027  Estrogen receptor alpha agonist
0,120  0,118  Phospholipase A2 inhibitor
0,062  0,060  Glutamate (mGluR6) antagonist
0,080  0,078  Tocolytic
0,114  0,113  Src kinase inhibitor
0,017  0,016  Inosine monophosphate dehydrogenase 2 inhibitor

